SCHEMBL7629630

SCHEMBL7629630

COc1ccc2c(c1)C(c1ccccc1)CNCC2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.66
HTR2A P28223 1/20 0.66
HTR2B P41595 1/20 0.66
DRD1 P21728 13/20 0.65
DRD2 P14416 8/20 0.65
DRD5 P21918 3/20 0.64
TAAR1 Q96RJ0 1/20 0.61
KDM4E B2RXH2 3/20 0.59
HPGD P15428 3/20 0.59
MAPT P10636 2/20 0.59
ADCY6 O43306 1/20 0.59
ADCY3 O60266 1/20 0.59
ADCY9 O60503 1/20 0.59
ADCY5 O95622 1/20 0.59
ADCY8 P40145 1/20 0.59
ADCY7 P51828 1/20 0.59
ADCY2 Q08462 1/20 0.59
ADCY1 Q08828 1/20 0.59
ADCY4 Q8NFM4 1/20 0.59
CYP3A4 P08684 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10345386 0.99 DRD1 (0.66) HTR2CHTR2AHTR2BDRD1DRD2
SCHEMBL10746447 0.87 HTR2C (0.63) HTR2CHTR2AHTR2BDRD1DRD2
SCHEMBL10745233 0.86 HTR2C (0.59) HTR2CHTR2AHTR2BDRD1DRD2
SCHEMBL10345842 0.84 HTR2C (0.56) HTR2CHTR2AHTR2BDRD1DRD2
SCHEMBL10746722 0.82 HTR2C (0.54) HTR2CHTR2AHTR2BDRD1DRD2
SCHEMBL7320752 0.82 DRD1 (0.81) DRD1DRD2DRD5TAAR1KDM4E
SCHEMBL7620194 0.82 DRD1 (0.81) DRD1DRD2DRD5TAAR1KDM4E
SCHEMBL7621209 0.82 DRD1 (0.81) DRD1DRD2DRD5TAAR1KDM4E
SCHEMBL10345843 0.81 HTR2C (0.59) HTR2CHTR2AHTR2BDRD1DRD2
Fumaric Acid SCHEMBL10345846 0.81 DRD1 (0.57) HTR2CHTR2AHTR2BDRD1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0005300-A1 Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for the preparation thereof, and pharmaceutical compositions containing them Technobiotic Ltd. (CH) 1979-11-14 EP claimed
US-20020019389-A1 Urea derivative useful as an anti-cancer agent and process for preparing same CHACONNE NSI CO., LTD. (KR) 2002-02-14 US disclosed
US-4707483-A 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders SMITHKLINE BECKMAN CORPORATION (US) 1987-11-17 US disclosed
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019389-A1 Urea derivative useful as an anti-cancer agent and process for preparing same UTS2R, SLC14A1, URB2 HTR2C 4541/4885HTR2A 4342/4885HTR2B 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.